Free Cash Flow Chart

View Free Cash Flow for BXRXQ.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Free Cash Flow Chart
Start Trial

Historical Free Cash Flow Data

View and export this data back to 2018. Start Trial.
Date Value
September 30, 2023 -14.64M
June 30, 2023 -26.11M
March 31, 2023 -19.05M
December 31, 2022 -27.81M
September 30, 2022 -36.78M
June 30, 2022 -35.35M
March 31, 2022 -48.82M
December 31, 2021 -49.47M
September 30, 2021 -51.66M
June 30, 2021 -51.21M
Date Value
March 31, 2021 -52.46M
December 31, 2020 -44.70M
September 30, 2020 -37.36M
June 30, 2020 -28.19M
March 31, 2020 -42.94M
December 31, 2019 -51.36M
September 30, 2019 -57.89M
June 30, 2019 -70.87M
March 31, 2019 -59.25M
December 31, 2018 -63.12M

Free Cash Flow Range, Past 5 Years

View Free Cash Flow Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Free Cash Flow Benchmarks

View Free Cash Flow Benchmarks
Start Trial
ANI Pharmaceuticals, Inc. 167.52M
Corcept Therapeutics, Inc. 106.92M
Veru, Inc. -26.04M
Johnson & Johnson 22.61B
Eli Lilly & Co. 13.56B